title: Elevated glucose concentrations inhibit DNA synthesis and expression of c-myc in cultured hepatocytes.
abstract: Glucose depressed DNA synthesis in rat hepatocytes in primary culture. As compared to controls cultured with 5.6 mM glucose, maximal (> or = 75%) inhibition was obtained at 20-30 mM, and half-maximal effect at 10-15 mM. Comparison of D- and L-glucose showed that the effect was specific for the D-form. Maximal inhibition required the presence of glucose during the first 24 hours of culture. The expression of the c-myc gene was reduced when the hepatocytes were cultured in the presence of elevated glucose. The responses to epidermal growth factor, insulin and vasopressin, in terms of percentual stimulation of DNA synthesis, were qualitatively similar at 5.6 and 16.8 mM glucose, while glucagon stimulated more strongly when the glucose concentration was increased; glucagon at concentrations > or = 1 nM reversed the inhibition by glucose. 8-Br-cAMP mimicked the effect of glucagon. These results suggest that an increase in the level of glucose depresses hepatocyte DNA synthesis. The effect is associated with lowered expression of the c-myc gene and is counteracted by cAMP.
authors.affiliation: Department of Pharmacology, Faculty of Medicine, University of Oslo, Blindern, Norway.
authors.forename: O F
authors.initials: OF
authors.lastname: Dajani
authors.forename: M
authors.initials: M
authors.lastname: Refsnes
authors.forename: T K
authors.initials: TK
authors.lastname: Guren
authors.forename: R S
authors.initials: RS
authors.lastname: Horn
authors.forename: G H
authors.initials: GH
authors.lastname: Thoresen
authors.forename: T
authors.initials: T
authors.lastname: Christoffersen
mesh_terms: D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000378:metabolism / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis*; D004789:Enzyme Activation / Q000502:physiology; D004815:Epidermal Growth Factor / Q000502:physiology; D005786:Gene Expression Regulation / Q000187:drug effects*; D016259:Genes, myc; D005934:Glucagon / Q000502:physiology; D005947:Glucose / Q000378:metabolism* / Q000494:pharmacology; D007328:Insulin / Q000502:physiology; D008099:Liver / Q000166:cytology / Q000378:metabolism*; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D014667:Vasopressins / Q000502:physiology
chemical_list: D007328:Insulin; D014667:Vasopressins; D004815:Epidermal Growth Factor; D004247:DNA; D005934:Glucagon; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D005947:Glucose